Wedbush Reiterates Outperform on Staar Surgical, Maintains $40 Price Target

Benzinga · 08/04 12:55
Wedbush analyst Michael Piccolo reiterates Staar Surgical (NASDAQ:STAA) with a Outperform and maintains $40 price target.